A Presenilin 1 Mutation Associated with Familial Frontotemporal Dementia Inhibits γ-Secretase Cleavage of APP and Notch

作者: Zareen Amtul , Patrick A. Lewis , Sian Piper , Richard Crook , Matt Baker

DOI: 10.1006/NBDI.2001.0473

关键词: NeurodegenerationPresenilin 1 mutationPhenotypeMolecular biologyGeneticsPresenilinChemistryNeurologyCleavage (embryo)Frontotemporal dementiaDementia

摘要: Abstract A novel presenilin 1 mutation, insR352, associated with a frontal temporal dementia phenotype has been identified (E. A. Rogaeva et al., 2001, Neurology 57, 621–625). This mutation does not increase Aβ42 levels, but instead acts as dominant negative presenilin, decreasing amyloid β protein (Aβ) production by inhibiting γ-secretase cleavage of the Aβ precursor. The distinct clinical this suggests that chronic partial inhibition activity may result in neurodegeneration.

参考文章(15)
Michael S. Wolfe, Weiming Xia, Beth L. Ostaszewski, Thekla S. Diehl, W. Taylor Kimberly, Dennis J. Selkoe, Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature. ,vol. 398, pp. 513- 517 ,(1999) , 10.1038/19077
Eric H. Schroeter, Jeffrey A. Kisslinger, Raphael Kopan, Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature. ,vol. 393, pp. 382- 386 ,(1998) , 10.1038/30756
E. A. Rogaeva, K.C. Fafel, Y.Q. Song, H. Medeiros, C. Sato, Y. Liang, E. Richard, E.I. Rogaev, P. Frommelt, A. D. Sadovnick, W. Meschino, K. Rockwood, M. A. Boss, R. Mayeux, P. St. George-Hyslop, Screening for PS1 mutations in a referral-based series of AD cases: 21 Novel mutations Neurology. ,vol. 57, pp. 621- 625 ,(2001) , 10.1212/WNL.57.4.621
D. Tang-Wai, P. Lewis, B. Boeve, M. Hutton, T. Golde, M. Baker, J. Hardy, V. Michels, R. Ivnik, C. Jack, R. Petersen, Familial frontotemporal dementia associated with a novel presenilin-1 mutation. Dementia and Geriatric Cognitive Disorders. ,vol. 14, pp. 13- 21 ,(2002) , 10.1159/000058328
Nitin D. Mehta, Lawrence M. Refolo, Chris Eckman, Sunny Sanders, Debra Yager, Jordi Perez-Tur, Steve Younkin, Karen Duff, John Hardy, Mike Hutton, Increased Aβ42(43) from cell lines expressing presenilin 1 mutations Annals of Neurology. ,vol. 43, pp. 256- 258 ,(1998) , 10.1002/ANA.410430217
Todd E. Golde, Steven G. Younkin, Presenilins as therapeutic targets for the treatment of Alzheimer's disease Trends in Molecular Medicine. ,vol. 7, pp. 264- 269 ,(2001) , 10.1016/S1471-4914(01)02064-0
Karen Duff, Chris Eckman, Cindy Zehr, Xin Yu, Cristian-Mihail Prada, Jordi Perez-tur, Mike Hutton, Luc Buee, Yasuo Harigaya, Debra Yager, David Morgan, Marcia N. Gordon, Leigh Holcomb, Lawrence Refolo, Brenda Zenk, John Hardy, Steven Younkin, Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1 Nature. ,vol. 383, pp. 710- 713 ,(1996) , 10.1038/383710A0
J Hardy, Amyloid, the presenilins and Alzheimer's disease Trends in Neurosciences. ,vol. 20, pp. 154- 159 ,(1997) , 10.1016/S0166-2236(96)01030-2
Michael Paul Murphy, Lesley Jill Hickman, Christopher Benjamin Eckman, Sacha Noelle Uljon, Rong Wang, Todd Eliot Golde, γ-Secretase, Evidence for Multiple Proteolytic Activities and Influence of Membrane Positioning of Substrate on Generation of Amyloid β Peptides of Varying Length * Journal of Biological Chemistry. ,vol. 274, pp. 11914- 11923 ,(1999) , 10.1074/JBC.274.17.11914
A. Kammesheidt, F. M. Boyce, A. F. Spanoyannis, B. J. Cummings, M. Ortegon, C. Cotman, J. L. Vaught, R. L. Neve, Deposition of beta/A4 immunoreactivity and neuronal pathology in transgenic mice expressing the carboxyl-terminal fragment of the Alzheimer amyloid precursor in the brain Proceedings of the National Academy of Sciences of the United States of America. ,vol. 89, pp. 10857- 10861 ,(1992) , 10.1073/PNAS.89.22.10857